Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Sinomin Biotechnology is a specialized life sciences company based in Chengdu, China, that focuses on the research, development, and manufacturing of high-end pharmaceutical intermediates. The company is particularly recognized for its expertise in chiral chemistry and the production of unnatural amino acids, which serve as essential building blocks for modern drug discovery. Sinomin provides integrated Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) services to a global clientele, supporting projects from early-stage R&D through to commercial production. Their technical strengths include asymmetric synthesis, chiral resolution, and high-pressure hydrogenation. By maintaining stringent quality control and GMP-compliant processes, the company facilitates the development of innovative small molecule and peptide-based therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Sinomin Biotechnology.